Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Werner Enterprises (WERN)
209K → 205K shares (−2%)
Umh Properties (UMH)
595K → 581K shares (−3%)
Axsome Therapeutics (AXSM)
37K → 36K shares (−2%)
Steel Dynamics (STLD)
71K → 38K shares (−47%)
Tiptree (TIPT)
494K → 485K shares (−2%)
Voyager Technologies, Inc. (VOYG)
272K → 267K shares (−2%)
Smithfield Foods (SFD)
374K → 351K shares (−6%)
Evolent Health (EVH)
1.6M → 1.57M shares (−2%)
Apogee Therapeutics Inc.
123K → 64K shares (−48%)
Ionis Pharmaceuticals (IONS)
112K → 106K shares (−5%)
Neurocrine Biosciences (NBIX)
55K → 49K shares (−10%)
Hamilton Insurance Group (HG)
250K → 243K shares (−3%)
Adeia, Inc. (ADEA)
277K → 249K shares (−10%)
Kelly Services (KELYA)
676K → 663K shares (−2%)
Red Violet (RDVT)
127K → 125K shares (−2%)
Diodes Incorporated (DIOD)
171K → 72K shares (−58%)
Disc Medicine (IRON)
108K → 107K shares (−1%)
Centene Corporation (CNC)
123K → 121K shares (−1%)
Abeona Therapeutics (ABEO)
1.26M → 1.24M shares (−2%)
Ventas (VTR)
88K → 85K shares (−3%)
Veeco Instruments Inc. (VECO)
230K → 98K shares (−57%)
Vistance Networks (VISN)
592K → 581K shares (−2%)
TruBridge, Inc.
284K → 279K shares (−2%)
Ultragenyx Pharmaceutical (RARE)
219K → 216K shares (−2%)
Brown & Brown (BRO)
145K → 112K shares (−23%)
